C3 and metabolic dysfunction-associated steatohepatitis: Since factor H accelerates the decay of the alternative pathway C3 convertase, thereby restricting C3 activation, the observed low expression of factor H might underlie the increased hepatic C3c levels that we detected in the livers of subjects with NASH.